QIAGEN N.V. (QGEN) vs Twist Bioscience Corporation (TWST)
QIAGEN N.V. and Twist Bioscience Corporation are both Diagnostics & Research companies. Twist Bioscience Corporation is the larger, with a market value of $12.4B against $9.3B — 1.3× the size. Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; QIAGEN N.V. trades at 22.6×. Twist Bioscience Corporation grew revenue faster over the last twelve months: 19.2% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs −31.7%) and the higher return on invested capital (6.62% vs −30.8%). Across the 19 metrics below, QIAGEN N.V. leads on 16 and Twist Bioscience Corporation on 3.
Valuation
Profitability
| Metric | QGEN | TWST | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 62.20% | 51.97% | 50.89% |
| Operating margin | 21.21% | (33.58%) | (8.57%) |
| Net margin | 19.49% | (31.66%) | (6.37%) |
| Free cash flow margin | 20.98% | (22.15%) | 0.00% |
| Return on equity | 11.93% | (29.59%) | (2.92%) |
| Return on assets | 6.99% | (20.78%) | (6.71%) |
| Return on invested capital | 6.62% | (30.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack